Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

OBJECTIVE: This study aims at investigating the potential prognostic significance of the breast immune prognostic index (BIPI) in breast cancer patients who received neoadjuvant chemotherapy (NACT). METHODS: The optimal cutoff value was calculated through the receiver operating characteristic curve...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li, Kong, Xiangyi, Huang, Shaolong, Su, Zhaohui, Zhu, Mengliu, Fang, Yi, Zhang, Lin, Li, Xingrui, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937039/
https://www.ncbi.nlm.nih.gov/pubmed/35320931
http://dx.doi.org/10.3389/fimmu.2022.831848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937039/
https://www.ncbi.nlm.nih.gov/pubmed/35320931
http://dx.doi.org/10.3389/fimmu.2022.831848

Ejemplares similares